Effect of Medicinal Plants and Natural Products on Liver Enzymes in Non‑alcoholic Fatty Liver Patients in Iran: A Systematic Review and Meta‑Analysis

Moloud Fakhri, Hafez Fakheri, Mohammad Azadbakht, Mahmood Moosazadeh, Seyde Sedighe Yousefi

Abstract


Background: Nonalcoholic fatty liver is the most common chronic liver disease. Regarding the side effects of synthetic medicines and the variety of natural products in Iran climate, the present study aimed to investigate the effect of medicinal plants and natural products on liver enzymes in patients with non‑alcoholic fatty liver disease in Iran using meta‑analysis. Methods: To extract the intended studies, internal and external databases, including SID, Magiran, IranDoc, PubMed, Scopus, Web of Science, Embase, Cochrane, and Clinical Trial Registration System of Clinical trial.gov, the ISRCTN system, as well as Clinical Trial Registration System affiliated to the World Health Organization were searched. The obtained data were analyzed in STATA.14 software. A P value less than 0.05 was considered statistically significant. Results: A total of 44 rstudies were reviewed with a sample size of 1298 participant; they were published in the period from 2009 to 2018, silymarin had the highest effect on the reduction of AST (SMD = ‑2.68), cinnamon excreted the most profound effect on ALT (SMD = ‑2.69). In addition, cinnamon had the highest effect on gamma‑glutamyl transferase (GGT) (SMD:‑3.17), and curcumin had the highest effect on alkaline phosphatase (ALP) (SMD = ‑1.88). In the lipid profile, the effect of medicinal herbs and natural products on lowering total cholesterol and LDL was statistically significant. In the glycemic profile, the effect of medicinal plants and natural products on the reduction of fasting blood sugar, insulin, and hemoglobin A1c levels was statistically significant. Conclusions: As evidenced by the obtained results, the highest effect of using natural products was observed in the reduction of GGT, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels, respectively; nonetheless, the effect of natural products on ALP reduction was not statistically significant.

Keywords


Biological products; herbal medicine; Iran; medicinal; non‑alcoholic fatty liver disease; plants; therapeutics

Full Text:

PDF

References


Angulo P. Nonalcoholic fatty liver disease. N Engl J Med

;346:1221‑31.

Obika M, Noguchi H. Diagnosis and evaluation of nonalcoholic

fatty liver disease. Exp Diabetes Res 2012;2012:145754.

Abenavoli L, Milic N, Di Renzo L, Preveden T,

Medić‑Stojanoska M, De Lorenzo A. Metabolic aspects of

adult patients with nonalcoholic fatty liver disease. World J

Gastroenterol 2016;22:7006‑16.

Dyson J, Anstee Q, McPherson S. Non‑alcoholic fatty liver

disease: A practical approach to diagnosis and staging. Frontline

Gastroenterol 2014;5:211‑8.

Iloon Kashkooli R, Najafi S, Sharif F, Hamedi A, Hoseini Asl M,

Najafi Kalyani M, et al. The effect of berberis vulgaris extract

on transaminase activities in non‑alcoholic Fatty liver disease.

Hepat Mon 2015;15:e25067.

Moghaddasifar I, Lankarani KB, Moosazadeh M, Afshari M,

Ghaemi A, Aliramezany M, et al. Prevalence of non‑alcoholic

fatty liver disease and its related factors in Iran. Int J Organ

Transplant Med 2016;7:149‑60.

Lankarani K, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N,

Heydari S, et al. Non alcoholic fatty liver disease in southern

Iran: A population based study. Hepat Mon 2013;13:e9248.

Gu C‑l, Zhang Y‑k, Fu Y‑x, Yang S‑f, Li X‑q. Effect of Tiaozhi

Yanggan Decoction in treating patients with non‑alcoholic fatty

liver. Chin J Integr Med 2007;13:275‑9.

Ford R, Fullerton M, Pinkosky S, Day E, Scott J, Oakhill J, et al.

Metformin and salicylate synergistically activate liver AMPK,

inhibit lipogenesis and improve insulin sensitivity. Biochem J

;468:125‑32.

Choi Y, Yanagawa Y, Kim S, Park T. Involvement of

SIRT1‑AMPK signaling in the protective action of

indole‑3‑carbinol against hepatic steatosis in mice fed a high‑fat

diet. J Nutr Biochem 2013;24:1393‑400.

Yan F, Wang Q, Xu C, Cao M, Zhou X, Wang T, et al.

Peroxisome proliferator‑activated receptor α activation induces

hepatic steatosis, suggesting an adverse effect. PLoS One

;9:e99245.

Bahmani M, Rafieian‑Kopaei M, Hassanzadazar H, Saki K,

Karamati S, Delfan B. A review on most important herbal

and synthetic antihelmintic drugs. Asian Pac J Trop Med

;7:29‑33.

Bahmani M, Rafieian‑Kopaei M, Jeloudari M, Eftekhari Z,

Delfan B, Zargaran A, et al. A review of the health effects and

uses of drugs of plant licorice (Glycyrrhiza glabra L.) in Iran.

Asian Pac J Trop Dis 2014;4:847‑9.

Rafieian‑Kopaei M. In vitro evaluation of antioxidant properties

of ten Iranian medicinal plants. Iran Red Crescent Med J

;16:e10264.

Rafieian‑Kopaei M, Baradaran A, Rafieian M. Plants antioxidants:

From laboratory to clinic. J Nephropathol 2013;2:152‑3.

Sedighi M, Rafieian‑kopaei M, Noori‑Ahmadabadi M. Kelussia

odoratissima Mozaffarian inhibits ileum contractions through

voltage dependent and beta adrenergic receptors. Life Sci

;9:1033–8.

Farnsworth N, Akerele O, Bingel A, Soejarto D, Guo Z.

Medicinal plants in therapy. Bull World Health Organ

;63:965‑81.

Bai R, Paull K, Herald C, Malspeis L, Pettit G, Hamel E.

Halichondrin B and homohalichondrin B, marine natural

products binding in the vinca domain of tubulin. Discovery of

tubulin‑based mechanism of action by analysis of differential

cytotoxicity data. J Biol Chem 1991;266:15882‑9.

Newman D, Cragg G, Snader K. The influence of natural

products upon drug discovery. Nat Prod Rep 2000;17:215‑34.

Madihi Y, Merrikhi A, Baradaran A, Ghobadi S, Shahinfard N,

Ansari R, et al. Bioactive components and the effect of

hydroalcoholic extract of Vaccinium myrtillus on postprandial

atherosclerosis risk factors in rabbits. Pak J Med Sci

;29:384–9.

Hasanpour Z, Nasri H, Rafieian‑Kopaei M, Ahmadi A,

Baradaran A, Nasri P, et al. Paradoxical effects of atorvastatin on

renal tubular cells an experimental investigation. Iran J Kidney

Dis 2015;9:215‑20.

Rabiei Z, Rafieian‑Kopaei M, Heidarian E, Saghaei E,

Mokhtari S. Effects of Zizyphus jujube extract on memory

and learning impairment induced by bilateral electric lesions

of the nucleus Basalis of Meynert in rat. Neurochem Res

;39:353‑60.

Nikkhajoei M, Choopani R, Tansaz M, Heydarirad G,

Hashem‑Dabaghian F, Sahranavard S, et al. Herbal medicines

used in treatment of nonalcoholic fatty liver disease:

A mini‑review. Galen Med J 2016;5:107‑13.

Fleischman MW, Budoff M, Ifran Zeb DL, Foster T. NAFLD

prevalence differs among hispanic subgroups: The multi‑ethnic

study of atherosclerosis. World J Gastroenterol 2014;20:4987‑93.

Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A,

Petticrew M, et al. Preferred reporting items for systematic

review and meta‑analysis protocols (PRISMA‑P) 2015 statement.

Syst Rev 2015;4:1.

Shi K, Fan Y, Liu W, Li L, Chen Y, Zheng M. Traditional

Chinese medicines benefit to nonalcoholic fatty liver disease:

A systematic review and meta‑analysis. Mol Biol Rep

;39:9715–22.

Iran Institute of Information Technology. Available from: http://

www.irandoc.ac.ir/.

Available from: https://clinicaltrials.gov/.

Available from: https://www.isrctn.com/.

Available from: https://www.who.int/emergencies/diseases/

novel-coronavirus-2019?gclid=CjwKCAjw2a32BRBXEiwA

UcugiF8TCQCLeaSWC3Eb3G2D_oiUqQ2DPPfMDBZxVefWFglTD1lQvUHaRoCB5UQAvD_BwE.

Higgins JP, Thompson SG. quantifying heterogeneity in a

meta‑analysis. Stat Med 2002;21:1539‑58.

Ekhlasi G, Shidfar F, Agah S, Merat S, Hosseini A. Does daily

intake of orange juice along with weight loss diet affect serum

lipoprotein profiles in patients with nonalcoholic fatty liver

disease. Iranian J Endocrinol Metab 2014;15:435‑42.

Zamani N, Shams M, Nimrouzi M, Zarshenas M, Foroughi A,

Abarghooei E, et al. The effects of Zataria multiflora

Boiss. (Shirazi thyme) on nonalcoholic fatty liver disease and

insulin resistance: A randomized double‑blind placebocontrolled

clinical trial. Complement Ther Med 2018;41:118‑23.

Khavasi N, Hosein Somi M, Khadem E, Faramarz iE, Ayati M,

Fazljou S, et al. Effect of daily caper fruit pickle consumption

on disease regression in patients with non‑alcoholic fatty liver

disease: A double‑blinded randomized clinical trial. Adv Pharm

Bull 2017;7:645‑50.

Askari F, Abadi A, Rashidkhani B, Ghafari S, Jalali M,

Hekmatdoost A. Effect of cinnamon on lipid profile, liver

enzymes, insulin resistance and hs ‑CRP inflammatory factor in

patients with nonalcoholic fatty liver disease. J Res Dev Nurs

Midw 2013;10:47‑55.

Yari Z, Rahimlu M, Poustchi H, Ebrahimi Daryani N,

Hekmatdoost A. Effect of faxseed supplementation on liver

enzymes, hepatic fibrosis and steatosis in nonalcoholic fatty liver

disease: A randomized‑controlled clinical trial. Iranian journal of

nutrition sciences & food technology 2016;10:1‑12.

Hasani A, Ansari R, Mazani A. Effect of 8 weeks of aerobic

training and using chicory extractive supplementation on serum

levels of ALT and AST enzymes in women with fatty liver.

The Iranian Journal of Obstetrics, Gynecology and Infertility

;19:1‑8.

Rahimlou M, Yari Z, Hekmatdoost A, Alavian M, Keshavarz A.

Effect of ginger supplementation on liver enzymes, hepatic

fibrosis and steatosis in nonalcoholic fatty liver disease: A double

blind randomized‑controlled clinical trial. Iran J Nutr Sci Food

Technol 2016;11:1‑8.

Milajerdi A, Jazayeri A, Jazayeri S, Hashemzadeh N, Shirzadi E,

Derakhshan Z, et al. The effect of hydro‑alcoholic extract of

saffron stigma (crocus sativus l.) on metabolic control parameters,

liver enzymes, and renal function parameters in type 2 diabetic

patients. Journal of Medicinal Plants 2016;15:142‑51.

Fathei M, Khairabadi S, Ramezani F, Hejazi K. The effects of

eight weeks aerobic training, green tea supplementation and

compound of them on serum liver enzymes and apolipoproteins

in inactive overweight women. MJMS 2016;59:114‑23.

Esmaelzadeh Toloee M, Faramarzi M, Noroozian P. Effect of

aerobic training with ginger supplementation on some liver

enzymes (AST, ALT, GGT) and resistance to insulin in obese

women with type 2 diabetes. Medical J Mashhad University of

Medical Sciences 2017;60:636‑47.

Beheshti Namdar A, Bahari A, Vosughinia H, Saadatnia H,

Esmaeelzade A, Ganji A, et al. Comparing the effect of flaxseed

oil with vitamin E on non‑invasive markers of liver in patients

with nonalcoholic fatty liver disease. Medical J Mashhad

University of Medical Sciences 2015;57:890‑7.

Moradi‑Kelardeh B, Azarbayjani M, Peeri M, Matinhomaee H.

Effect of curcumin supplementation and resistance training

in patients with nonalcoholic fatty liver disease. Journal of

Medicinal Plants 2016;4:161‑72.

Sheybani Asl Z, Malekirad A, Abdollahi M, Bakhshipour A,

Dastjerdi H, Mostafalou S, et al. Effects of the mixture of

cichorium intybus L. and cinnamomum zeylanicum on hepatic

enzymes activity and biochemical parameters in patients with

nonalcoholic fatty liver disease. Health 2014;6:1212‑7.

Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M,

Feizi A, et al. Treatment of non‑alcoholic fatty liver disease with

curcumin: A randomized placebo‑controlled trial. Phytother Res

;30:1540–8.

Panahi Y, Kianpour P, Mohtashami R, Jafari R,

Simental‑Mendía L, Sahebkar A. Efficacy and safety of

phytosomal curcumin in non‑alcoholic fatty liver disease:

A randomized controlled trial. Drug Res (Stuttg) 2017;67:244‑51.

Ebrahimi‑Mameghani M, Sadeghi Z, Farhangi M,

Vaghef‑Mehrabany E, Aliashrafi S. Glucose homeostasis,

insulin resistance and inflammatory biomarkers in patients

with non‑alcoholic fatty liver disease: Beneficial effects

of supplementation with microalgae Chlorella vulgaris:

A double‑blind placebo‑controlled randomized clinical trial. Clin

Nutr 2017;36:1001‑6.

Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol

supplementation improves inflammatory biomarkers in patients

with nonalcoholic fatty liver disease. Nutr Res 2014;34:837‑43.

Famouri F, Salehi M, Rostampour N, Hashemi E, Shahsanaee A.

The effect of silymarin on non‑alcoholic fatty liver disease of

children. J Herbmed Pharmacol 2017;6:16‑20.

Amanat S, Eftekhari M, Bagheri Lankarani K, Fararouei M.

Effect of genistein supplementation on insulin sensitivity,

insulin resistance, and beta cells function index in patients with

non‑alcoholic fatty liver disease: A randomized, controlled trial.

Iran J Nutr Sci Food Technol 2018;13:1‑10.

Hajiaghamohammadi A, Ziaee A, Samimi R. The efficacy of

licorice root extract in decreasing transaminase activities in non‐

alcoholic fatty liver disease: A randomized controlled clinical

trial. Phytother Res 2012;26:1381‑4.

Panahi Y, Ghamarchehreh M, Beiraghdar F, Zare R, Jalalian H,

Sahebkar A. Investigation of the effects of Chlorella vulgaris

supplementation in patients with non‑alcoholic fatty liver

disease: A randomized clinical trial. Hepatogastroenterol

;59:2099‑103.

Pezeshki A, Safi S, Feizi A, Askari G, Karami F. The effect of

green tea extract supplementation on liver enzymes in patients

with nonalcoholic fatty liver disease. Int J Prev Med 2016;7:28.

Hashemi S, Hajiani E, Heydari S. A Placebo‑controlled trial of

silymarin in patients with nonalcoholic fatty liver disease. Hepat

Mon 2009;9:265‑70.

Ahmadian M. PhD Thesis pills on nonalcoholic fatty

liver [persian] 2013.

Talebi Pour B, Jameshorani M, Salmani R. The effect of

Chlorella Vulgaris vs. Artichoke on patients with non‑alcoholic

fatty liver disease (NAFLD): A randomized clinical trial. J Adv

Med Biomed Res 2015;23:36‑44.

Aliashrafi S, Ebrahimi Mameghani M, Kakaie F, Javadzadeh Y,

Asghari Jafarabadi M. The effect of microalgae chlorella vulgaris

supplementation on inflammatory factors in non‑alcoholic fatty

liver disease (NAFLD): A double‑blind randomized clinical

trial [persian]. J Mazand Univ Med Sci 2014;24:113‑21.

Taghvaei T, Bahar A, Hosseini V, Maleki I, Kasrai M. Efficacy of

silymarin on treatment of nonalcoholic steatohepatitis [persian].

J Mazand Univ Med Sci 2013;23:164‑71.

Iranikhah A, Shapouri J, Heydari A, Aghaali M, Hajian H.

Effects of silymarin on nonalcoholic fatty liver disease in

children: A crossover clinical trial [persian]. J Mazandaran Univ

Med Sci 2016;26:119‑26.

Hajaghamohammadi A, Ziaee A, Rafiei R. The efficacy of

silymarin in decreasing transaminase activities in non‑alcoholic

fatty liver disease: A randomized controlled clinical trial. Hepat

Mon 2008;8:191‑5.

Hajiaghamohammadi A, Ziaee A, Oveisi S, Masroor H.

Effects of metformin, pioglitazone, and silymarin treatment on

non‑alcoholic fatty liver disease: A randomized controlled pilot

study. Hepat Mon 2012;12:e6099.

Anushiravania A, Haddadib N, Pourfarmanbarb M,

Mohammadkarimic V. Treatment options for nonalcoholic fatty

liver disease: A double‑blinded randomized placebo‑controlled

trial. Eur J Gastroenterol Hepatol 2019;31:613–7.

Saadati S, Sadeghi A, Mansour A, Yari Z, Poustchi H,

Hedayati M, et al. Curcumin and inflammation in nonalcoholic

fatty liver disease: A randomized, placebo controlled clinical

trial. BMC Gastroenterol 2019;19:133.

Saadati S, Hatami B, Yari Z, Shahrbaf M, Eghtesad S,

Mansour A, et al. The effects of curcumin supplementation on

liver enzymes, lipid profile, glucose homeostasis, and hepatic

steatosis and fibrosis in patients with non‑alcoholic fatty liver

disease. Eur J Clin Nutr 2019;73:441‑9.

Mirhafez S, Rezaei Farimani A, Dehhabe M, Bidkhori M,

Hariri M, Nobakht Motlagh Ghouchani B, et al. Effect of

phytosomal curcumin on circulating levels of adiponectin

and leptin in patients with non‑alcoholic fatty liver disease:

A randomized, double‑blind, placebo‑controlled clinical trial.

J Gastrointestin Liver Dis 2019;28:183‑9.

Jazayeri‑Tehrani S, Rezayat S, Mansouri S, Qorbani M,

Alavian S, Daneshi‑Maskooni M, et al. Nano‑curcumin

improves glucose indices, lipids, inflammation, and Nesfatin

in overweight and obese patients with nonalcoholic fatty liver

disease (NAFLD): A double‑blind randomized placebocontrolled

clinical trial. Nutr Metab 2019;16:8.

Ekhlasi G, Shidfar S, Agah S, Merat S, Agha Fatemeh Hosseini K.

Effect of pomegranate juice intake on lipid profile in patients with

nonalcoholic fatty liver disease. Razi J Med Sci 2013;20:31‑9.

Khavasi N, Somi M, Khadem E, Ayati M, Torbati M, Fazljou S.

Daily consumption of the capparis spinosa reduces some

atherogenic indices in patients with non‑alcoholic fatty liver

disease: A randomized, double‑blind, clinical trial. Iran Red

Crescent Med J 2018;20:e63446.

Tabatabaee S, Alavian S, Ghalichi L, Miryounesi S,

Mousavizadeh K, Jazayeri S, et al. Green tea in non‑alcoholic

fatty liver disease: A double blind randomized clinical trial.

Hepat Mon 2017;17:e14993.

Malekirad A, Vaezi G, Abdollahi M. Effects of mixture of

melissa officinalis L., cinnamomum zeylanicum and Urtica

dioica on hepatic enzymes activity in patients with nonalcoholic

fatty liver disease. Int J Pharmacol 2012;8:204‑8.

Solhi H, Ghahremani R, Kazemifar A, Hoseini‑Yazdi Z.

Silymarin in treatment of non‑alcoholic steatohepatitis:

A randomized clinical trial. Caspian J Intern Med 2014;5:9‑12.

Rangboo V, Noroozi M, Zavoshy R, Rezadoost S,

Mohammadpoorasl A. The effect of artichoke leaf extract on

alanine aminotransferase and aspartate aminotransferase in

the patients with nonalcoholic steatohepatitis. Int J Hepatol

;2016:4030476.

Masoodi M, Rezadoost A, Panahian M, Vojdanian M. Effects of

silymarin on reducing liver aminotransferases in patients with

nonalcoholic fatty liver diseases. Govaresh 2013;18:181‑5.

Panahi Y, Kianpour P, Mohtashami R, Atkin S, Butler A,

Jafari R, et al. Efficacy of artichoke leaf extract in non‐alcoholic

fatty liver disease: A pilot double‐blind randomized controlled

trial. Phytother Res 2018;32:1382‑7.

Fathi M, Khairabadi S, Ramezani F, Hejazi K. The effects of

eight weeks aerobic training, green tea supplementation and

compound of them on serum liver enzymes and apolipoproteins

in inactive overweight women. Medical J Mashhad University of

Medical Sciences 2016;59:114‑23.

Hasanpour AD. Influence of yoga and aerobics exercise on

fatigue, pain and psychosocial status in patients with multiple

sclerosis: A randomized trial. J Sports Med Phys Fitness

;56:1417‑22.

Farzaei M, Zobeiri M, Parvizi F, El‑Senduny F, Marmouzi I,

Coy‑Barrera E, et al. Curcumin in liver diseases: A systematic

review of the cellular mechanisms of oxidative stress and clinical

perspective. Nutrients 2018;10:855.

Mansour‑Ghanaei F, Pourmasoumi M, Hadi A, Joukar F.

Efficacy of curcumin/turmeric on liver enzymes in patients

with non‑alcoholic fatty liver disease: Asystematic review of

randomized controlled trials. Integr Med Res 2019;8:57‑61.

Akbarzadeh T, Sabourian R, Saeedi M, Rezaeizadeh H,

Khanavi M, Ardekani M. Liver tonics: Review of plants used

in Iranian traditional medicine. Asian Pac J Trop Biomed

;5:170‑81.

Moradi M, Asadi‑Samani M, Bahmani M, Shahrani M.

Medicinal plants used for liver disorders based on the

Ethnobotanical documents of Iran: A Review. Int J Pharmtech

Res 2016;9:407‑15.

de Avelar C, Pereira E, de Farias Costa P, de Jesus R,

de Oliveira L. Effect of silymarin on biochemical indicators in

patients with liver disease: Systematic review with meta‑analysis.

World J Gastroenterol 2017;23:5004‑17.

Zhong S, Fan Y, Yan Q, Fan X, Wu B, Han Y, et al. The

therapeutic effect of silymarin in the treatment of nonalcoholic

fatty disease: A meta‑analysis (PRISMA) of randomized control

trials. Medicine 2017;96:e9061.

Yin X, Yang J, Li T, Song L, Han T, Yang M, et al. The effect

of green tea intake on risk of liver disease: A meta analysis. Int J

Clin Exp Med 2015;8:8339‑46.

Jin X, Zheng R, Li Y. Green tea consumptionand liver disease:

A systematic review. Liver Int 2008;28:990‑6.